Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Works matching IS 14741776 AND DT 2012 AND VI 11 AND IP 4
Results: 28
1
2
Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain.
- Published in:
- 2012
- By:
- Publication type:
- journal article
3
Novel molecular targets for atrial fibrillation therapy.
- Published in:
- 2012
- By:
- Publication type:
- journal article
4
Trevor Mundel. Interview by Asher Mullard.
- Published in:
- 2012
- Publication type:
- Journal Article
5
Neuromuscular disorders: Troponin activator improves muscle function.
- Published in:
- 2012
- By:
- Publication type:
- journal article
6
Defining rewardable innovation in drug therapy.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 4, p. 253, doi. 10.1038/nrd3715
- By:
- Publication type:
- Article
7
Aflibercept.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 4, p. 269, doi. 10.1038/nrd3700
- By:
- Publication type:
- Article
8
Unleashing the Mini-Sentinel.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 4, p. 255, doi. 10.1038/nrd3713
- By:
- Publication type:
- Article
9
Neurological disorders: GM1 ganglioside improves motor function.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 4, p. 274, doi. 10.1038/nrd3709
- Publication type:
- Article
10
Obesity and diabetes: Adenosine kinase inhibitor increases ?-cells.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 4, p. 274, doi. 10.1038/nrd3710
- Publication type:
- Article
11
Hedgehog inhibitor gets landmark skin cancer approval, but questions remain for wider potential.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 4, p. 257, doi. 10.1038/nrd3714
- By:
- Publication type:
- Article
12
Deal watch: Biogen acquires Stromedix to pursue novel fibrosis therapy.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 4, p. 260, doi. 10.1038/nrd3708
- By:
- Publication type:
- Article
13
Cancer: GSK3? is a new target in leukaemia.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 4, p. 274, doi. 10.1038/nrd3712
- Publication type:
- Article
14
Rare diseases and orphan drugs.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 4, p. 267, doi. 10.1038/nrd3654
- By:
- Publication type:
- Article
15
Trevor Mundel.
- Published in:
- 2012
- Publication type:
- Interview
16
Neurological disorders: Inhibiting tau oligomerization.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 4, p. 274, doi. 10.1038/nrd3711
- Publication type:
- Article
17
Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 4, p. 292, doi. 10.1038/nrd3673
- By:
- Publication type:
- Article
18
Neurological disorders: A class of its own.
- Published in:
- 2012
- By:
- Publication type:
- journal article
19
Metabolic disease: Identifying novel targets of resveratrol.
- Published in:
- 2012
- By:
- Publication type:
- journal article
20
Stroke: Can PSD95 inhibitors widen the therapeutic window?
- Published in:
- 2012
- By:
- Publication type:
- journal article
21
Neurodegenerative disease: RXR agonist reverses Alzheimer's disease.
- Published in:
- 2012
- By:
- Publication type:
- journal article
22
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 4, p. 251, doi. 10.1038/nrd3721
- Publication type:
- Article
23
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 4, p. 259, doi. 10.1038/nrd3718
- Publication type:
- Article
24
Market watch: Upcoming market catalysts in Q2 2012.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 4, p. 260, doi. 10.1038/nrd3707
- By:
- Publication type:
- Article
25
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 4, p. 262, doi. 10.1038/nrd3719
- By:
- Publication type:
- Article
26
Novel molecular targets for atrial fibrillation therapy.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 4, p. 275, doi. 10.1038/nrd3682
- By:
- Publication type:
- Article
27
Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 4, p. 311, doi. 10.1038/nrd2909
- By:
- Publication type:
- Article
28
Targeting IAP proteins for therapeutic intervention in cancer.
- Published in:
- 2012
- By:
- Publication type:
- Correction Notice